Provided by Tiger Trade Technology Pte. Ltd.

TEDA BIOMEDICAL

0.160
-0.008-4.76%
Volume:65.00K
Turnover:10.46K
Market Cap:341.44M
PE:-3.66
High:0.161
Open:0.161
Low:0.160
Close:0.168
52wk High:0.540
52wk Low:0.114
Shares:2.13B
HK Float Shares:1.44B
Volume Ratio:0.30
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.044
ROE:-728.50%
ROA:-14.16%
PB:24.19
PE(LYR):-3.66
PS:0.57

Loading ...

TEDA Biomedical Reports No Share Capital Changes in May 2026 Monthly Return

Bulletin Express
·
Jun 03

Tianjin TEDA Biomedical Engineering files directors list with Hong Kong Exchange

Reuters
·
Jun 03

Tianjin TEDA Biomedical Engineering shareholders adopted AGM resolutions

Reuters
·
May 22

TEDA Biomedical: April 2026 Monthly Return Shows Stable 2.13 Billion Share Base and Public-Float Compliance

Bulletin Express
·
May 04

Tianjin TEDA Biomedical Engineering announces annual general meeting

Reuters
·
Apr 30

Tianjin TEDA Biomedical Engineering publishes 2025 annual report

Reuters
·
Apr 30

Tianjin TEDA Biomedical redesignates Xia Alan Zhe as non-executive director

Reuters
·
Apr 30

天津泰达生物聚焦双主业发力,2025年收入增长显著但亏损扩大

Bulletin Express
·
Apr 30

Executive Director Shifts to Non-Executive Role at TEDA BIOMEDICAL

Stock News
·
Apr 30

TEDA Biomedical 2025 Results: Revenue Up 35.7% to RMB 522.97 million, Net Loss Widens to RMB 90.82 million on One-off Impairments

Bulletin Express
·
Apr 01

TEDA Biomedical Reports Stable Share Capital and Sufficient Public Float for March 2026

Bulletin Express
·
Apr 01

TEDA BIOMEDICAL Appoints Lynn Li as Co-CEO

Stock News
·
Apr 01

TEDA BIOMEDICAL (08189) Announces Annual Results, Reports Shareholder Loss of 90.82 Million Yuan

Stock News
·
Apr 01

BRIEF-Tianjin Teda Biomedical Engineering Appoints Lynn Li As Joint CEO, Re-Designates Sun Li As Joint CEO

Reuters
·
Apr 01

Tianjin TEDA Biomedical Engineering - Appoints Lynn Li as Joint CEO, Re-Designates Sun Li as Joint CEO

THOMSON REUTERS
·
Mar 31

TEDA BIOMEDICAL Issues Profit Warning, Anticipates Annual Loss Attributable to Shareholders of Approximately 85 Million Yuan

Stock News
·
Mar 29

Tianjin TEDA Biomedical expects FY loss attributable to shareholders of about RMB 85 million

Reuters
·
Mar 29

TEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express
·
Mar 13

Tianjin TEDA Biomedical (08189) Announces February 2026 Monthly Return on Movements in Securities

Bulletin Express
·
Mar 02

Tianjin TEDA Biomedical Engineering (08189) Announces Monthly Return for January 2026

Bulletin Express
·
Feb 02